Selective oxidative stress and cholesterol metabolism in lipid-metabolizing cell classes: Distinct regulatory roles for pro-oxidants and antioxidants

BioFactors

Volumn 41, Issue 4, 2015, Pages 273-288

  Rosenblat, Mira ^a   Volkova, Nina ^a   Aviram, Michael ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Antioxidants; Cholesterol biosynthesis; Cholesterol efflux; Cholesterol influx; Intestinal cells; Liver cells; Macrophages; Oxidative stress; Paraoxonase

Indexed keywords

ANGIOTENSIN II; ANTIOXIDANT; ARYLDIALKYLPHOSPHATASE 1; CHOLESTEROL; FATTY ACID; GALLIC ACID; GLUCONOLACTONASE; GLUCOSE; GLUTATHIONE; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OLEIC ACID; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHOLIPID; POLYPHENOL DERIVATIVE; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; STEARIC ACID; TRIACYLGLYCEROL; ARYLDIALKYLPHOSPHATASE; COUMARIN DERIVATIVE; PHENOL DERIVATIVE; PON1 PROTEIN, HUMAN; RECOMBINANT PROTEIN; TRANS FATTY ACID; UNSATURATED FATTY ACID;

ADIPOCYTE; ANIMAL CELL; ARTICLE; ATHEROGENESIS; CHOLESTEROL METABOLISM; CHOLESTEROL SYNTHESIS; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; EMBRYO; FATTY ACID DESATURATION; FIBROBLAST; HT 29 CELL LINE; HUMAN; HUMAN CELL; INTESTINE CELL; LIPID METABOLISM; LIVER CELL; MACROPHAGE; MOUSE; NONHUMAN; OXIDATIVE STRESS; POMEGRANATE JUICE; PRIORITY JOURNAL; RED WINE; SMOOTH MUSCLE FIBER; AGONISTS; ANALYSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; ANTIBODY SPECIFICITY; BIOSYNTHESIS; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; FRUIT; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; LYTHRACEAE; METABOLISM; TUMOR CELL LINE; WINE;

LYTHRACEAE;

ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; ARYLDIALKYLPHOSPHATASE; CELL LINE, TUMOR; CHOLESTEROL; COUMARINS; EPITHELIAL CELLS; FATTY ACIDS; FATTY ACIDS, UNSATURATED; FRUIT; HEPATOCYTES; HUMANS; INTESTINAL MUCOSA; LIPID METABOLISM; LIPOPROTEINS, LDL; MACROPHAGES; MICE; ORGAN SPECIFICITY; OXIDATIVE STRESS; PHENOLS; PUNICACEAE; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; TRANS FATTY ACIDS; WINE;

EID: 84939564080     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1223     Document Type: Article

References (63)

1. Lusis, A. J. (2000) Atherosclerosis. Nature, 404, 233-241.
2. Carmena, R., Duriez, P., and Fruchart, J. C. (2004) Atherogenic lipoprotein particles in atherosclerosis. Circulation, 109, III2-III7.
3. Aviram, M. (2012) Atherosclerosis: cell biology and lipoproteins-paraoxonases (PONs) protect against atherosclerosis and diabetes development. Curr. Opin. Lipidol., 23, 169-171.
4. Moore, K. J. and Tabas, I. (2011) Macrophages in the pathogenesis of atherosclerosis. Cell, 145, 341-355.
5. Tiwari, R. L., Singh, Y., and Barthwal, M. K. (2008) Macrophages: an elusive yet emerging therapeutic target of atherosclerosis. Med. Res. Rev., 28, 483-544.
6. Lang, P. D. and Insull, W. J. (1970) Lipid droplets in atherosclerotic fatty streaks of human aorta. J. Clin. Invest., 49, 1479-1488.
7. Schulze, P. C. and Lee, R. T. (2005) Oxidative stress and atherosclerosis. Curr. Atheroscler. Rep., 7, 242-248.
8. Aviram, M. and Rosenblat, M. (2004) Paraoxonases 1, 2 and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free. Radic. Biol. Med., 37, 1304-1316.
9. Diestschy, J. M., Turley, S. D., and Spady, D. K. (1993) Role of liver in the maintenance of cholesterol and low density lipoprotein homeostasis in different animal species, including humans. J. Lipid. Res., 34, 1637-1659.
10. Kmieć, Z. (2001) Cooperation of liver cells in health and disease. Adv. Anat. Embryol. Cell. Biol., 161, III-XIII. 1-151.
11. Bourret, G., Brodeur, M. R., Luangrath, V., Lapointe, J., Falstrault, L, et al. (2006) In vivo cholesteryl ester selective uptake of mildly and standardly oxidized LDL occurs by both parenchymal and nonparenchymal mouse hepatic cells but SR-BI is only responsible for standardly oxidized LDL selective uptake by nonparenchymal cells. Int. J. Biochem. Cell. Biol., 38, 1160-1170.
12. Rinninger, F., Mann, W. A., Kaiser, T., Ahle, S., Meyer, N, et al. (1998) Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture. Atherosclerosis, 141, 273-285.
13. Groen, A. K., Oude Elferink, R. P., Verkade, H. J., and Kuipers, F. (2004) The ins and outs of reverse cholesterol transport. Ann. Med., 36, 135-145.
14. Basso, F., Freeman, L., Knapper, C. L., Remaley, A., Stonik, J, et al. (2003) Role of the hepatic ABCA1 transporter in modulating intrahepatic cholesterol and plasma HDL cholesterol concentrations. J. Lipid. Res., 44, 296-302.
15. Kruit, J. K., Groben, A. K., Van Berkel, T. J., and Kuipers, F. (2006) Emerging roles of the intestine in control of cholesterol metabolism. World. J. Gastroenterol., 12, 6429-6439.
16. Roheim, P. S., Gidez, L. I., and Eder, H. A. (1966) Extrahepatic synthesis of lipoproteins of plasma and chyle: role of the intestine. J. Clin. Invest., 45, 297-300.
17. Iqbal, J., Anwar, K., and Hussain, M. M. (2003) Multiple, independently regulated pathways for cholesterol transport across the intestinal epithelial cells. J. Bio. Chem., 278, 31610-31620.
18. Levy, E., Ben Djoudi Ouadda, A., Spahis, S., Sane, A. T., Garofalo, C, et al. (2013) PCSK9 plays a significant role in cholesterol homeostasis and lipid transport in intestinal epithelial cells. Atherosclerosis, 227, 297-306.
19. Lee-Rueckert, M., Blanco-Vaca, F., Kovanen, P. T., and Escola-Gil, J. C. (2013) The role of the gut in reverse cholesterol transport-focus on the enterocyte. Prog. Lipid. Res., 52, 317-328.
20. Brunham, L. R., Kruit, J. K., Iqbal, J., Fievet, C., Timmins, J. M, et al. (2006) Intestinal ABCA1 directly contributes to HDL biogenesis in vivo. J. Clin. Invest., 116, 1052-1062.
21. Tanaka, A., AI, M., Kobayashi, Y., Tamura, M., Shimokado, K, et al. (2001) Metabolism of triglyceride-rich lipoproteins and their role in atherosclerosis. Ann. N Y Acad. Sci., 947, 207-212.
22. Deferme, L., Briede, J. J., Claessen, S. M. H., Cavill, R., and Kleinjans, J. C. S. (2015) Cell line-specific oxidative stress in cellular toxicity a toxicogenomics-based comparison between liver and colon cell models. Toxicology. In. Vitro., 29, 845-855.
23. Francés, D., Ronco, M. T., Ochoa, E., Alvarez, M. L., Quiroga, A, et al. (2007) Oxidative stress in primary culture hepatocytes isolated from partially hepatectomized rats. Can. J. Physiol. Pharmacol., 85, 1047-1051.
24. Sauer, H., Wartenberg, M., and Hescheler, J. (2001) Reactive oxygen species as intracellular messengers during cell growth and differentiation. Cell. Physiol. Biochem., 11, 173-186.
25. Aviram, M. (1983) Plasma lipoprotein separation by discontinuous density gradient ultracentrifugation in hyperlipoproteinemic patients. Biochem. Med., 30, 111-118.
26. Lowry, O. H., Rosebrough, N. J., Farr AL, and Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
27. Aharoni, A., Gaidukov, L., Yagur, S., Toker, L., Silman, I, et al. (2004) Directed evolution of mammalian paraoxonases PON1 and PON3 for bacterial expression and catalytic specialization. Proc. Natl. Acad. Sci. U S A., 101, 482-487.
28. LeBel, C. P., Ischiropoulos, H., and Bondy, S. C. (1992) Evaluation of the probe 2', 7'-dichlorofluorescin as an indicator of reactive oxygen species formation and oxidative stress. Chem. Res. Toxicol., 5, 227-231.
29. Gaidukov, L. and Tawfik, D. S. (2005) High affinity, stability, and lactonase activity of serum paraoxonase PON1 anchored on HDL with ApoA-I. Biochemistry, 44, 11843-11854.
30. Buege, J. A. and Aust, D. S. (1978) Microsomal lipid peroxidation. Methods. Enzymol., 52, 302-310.
31. Bass, D. A., Parce, J. W., Dechatelet, L. R., Szejda, P., Seeds, M. C, et al. (1983) Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J. Immunol., 130, 1910-1917.
32. Gu, X., Kozarsky, K., and Krieger, M. (2000) Scavenger receptor class B, type I-mediated [3H] cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J. Biol. Chem., 275, 29939-30001.
33. Tabas, I., Weiland, D. A., and Tall, A. R. (1985) Unmodified low density lipoprotein causes cholesteryl ester accumulation in J774 macrophages. Proc Natl Acad Sci U S A., 82, 416-420.
34. Nestel, P. (2014) Trans fatty acids: are its cardiovascular risks fully appreciated?. Clin. Ther., 36, 315-321.
35. Ooi, E. M., Ng, T. W., Watts, G. F., and Barrett, P. H. (2013) Dietary fatty acids and lipoprotein metabolism: new insights and updates. Curr. Opin. Lipidol., 24, 192-197.
36. Jain, S. K. and Kannan, K. (2001) Chromium chloride inhibits oxidative stress and TNF-alpha secretion caused by exposure to high glucose in cultured U937 monocytes. Biochem. Biophys. Res. Commun., 289, 687-691.
37. Kaplan, M., Aviram, M., and Hayek, T. (2012) Oxidative stress and macrophage foam cell formation during diabetes mellitus- induced atherogenesis: role of insulin therapy. Pharmacology and Therapeutic., 136, 175-185.
38. Carnevale, R., Bartimoccia, S., Nocella, C., Di Santo, S., Loffredo, L, et al. (2014) LDL oxidation by platelets propagates platelet activation via an oxidative stress-mediated mechanism. Atherosclerosis, 237, 108-116.
39. Liao, W., Ning, Z., Chen, L., Wei, Q., Yuan, E, et al. (2014) Intracellular antioxidant detoxifying effects of diosmetin on 2, 2-azobis (2-amidinopropane) dihydrochloride (AAPH)-induced oxidative stress through inhibition of reactive oxygen species generation. J. Agric. Food. Chem., 62, 8648-8654.
40. Roks, A. J. (2015) Angiotensin II, oxidative stress and stem cell therapy: a matter of delicacy. Clin. Sci., 128, 749-750.
41. Draganov, D. I., Teiber, J. F., Speelman, A., Osawa, Y., Sunahara, R, et al. (2005) Human paraoxonases (PON1, PON2, and PON3) are lactonases with overlapping and distinct substrate specificities. J. Lipid. Res., 46, 1239-1247.
42. Shamir, R., Hartman, C., Karry, R., Pavlotzky, E., Eliakim, R, et al. (2005) Paraoxonases (PONs) 1, 2, and 3 are expressed in human and mouse gastrointestinal tract and in Caco-2 cell line: selective secretion of PON1 and PON2. Free. Radic. Biol. Med., 39, 336-344.
43. Rosenblat, M., Draganov, D., Watson, C. E., Bisgaier, C. L., La Du, B. N, et al. (2003) Mouse macrophage paraoxonase 2 activity is increased whereas cellular paraoxonase 3 activity is decreased under oxidative stress. Arterioscler. Thromb. Vasc. Biol., 23, 468-474.
44. Aviram, M., Rosenblat, M., Billecke, S., Erogul, J., Sorenson, R, et al. (1999) Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Free. Radic. Biol. Med., 26, 892-904.
45. Philips, M. C. (2014) Molecular mechanisms of cellular cholesterol efflux. J. Biol. Chem., 289, 24020-24029.
46. Marcil, V., Delvin, E., Sané, A. T., Tremblay, A., and Levy, E. (2006) Oxidative stress influences cholesterol efflux in THP-1 macrophages: role of ATP-binding cassette A1 and nuclear factors. Cardiovasc. Res., 72, 473-482.
47. Shao, B. (2012) Site-specific oxidation of apolipoprotein A-I impairs cholesterol export by ABCA1, a key cardioprotective function of HDL. Biochim. Biophys. Acta., 1821, 490-501.
48. Kohjima, M., Enjoji, M., Higuchi, N., Kato, M., Kotoh, K, et al. (2009) The effects of unsaturated fatty acids on lipid metabolism in HepG2 cells. In. Vitro. Cell. Dev. Biol. Anim., 45, 6-9.
49. Murthy, S., Albrght, E., Mathur, S. N., and Field, F. J. (1988) Modifications of CaCo-2 cell membrane fatty acid composition by eicosapentaenoic acid and palmitic acid: effect on cholesterol metabolism. J. Lipid. Res., 29, 773-780.
50. Gelsomino, G., Corsetto, P. A., Campia, I., Montorfano, G., Kopecka, J, et al. (2013) Omega 3 fatty acids chemosensitize multidrug resistant colon cancer cells by down-regulating cholesterol synthesis and altering detergent resistant membranes composition. Mol. Cancer., 12, 137.
51. Nagao, K., Nakamitsu, K., Ishida, H., Yoshinaga, K., Nagai, T, et al. Comparison of the lipid-lowering effects of four different n-3 highly unsaturated fatty acids in HepG2 cells. J. Oleo. Sci., 63, 979-985.
52. Rosenblat, M., Volkova, N., and Aviram, M. (2013) Pomegranate phytosterol (β-sitosterol) and polyphenolic antioxidant (punicalagin) addition to statin, significantly protected against macrophage foam cells formation. Atherosclerosis, 226, 110-117.
53. Rozenberg, O., Howell, A., and Aviram, M. (2006) Pomegranate juice sugar fraction reduces macrophage oxidative state, whereas white grape juice sugar fraction increases it. Atherosclerosis, 188, 68-76.
54. Schaefer, S., Baum, M., Eisenbrand, G., and Janzowski, C. (2006) Modulation of oxidative cell damage by reconstituted mixtures of phenolic applejuice extracts in human colon cell lines. Mol. Nutr. Food. Res., 50, 413-417.
55. Kaindl, U., Eyberg, I., Rohr-Udilova, N., Heinzle, C., and Marian, B. (2008) The dietary antioxidants resveratrol and quercetin protect cells from exogenous pro-oxidative damage. Food. Chem. Toxicol., 46, 1320-1326.
56. Boesch-Saadatmandi, C., Pospissil, R. T., Graeser, A. C., Canali, R., Boomgaarden, I, et al. (2009) Effect of quercetin on paraoxonase 2 levels in RAW264.7 macrophages and in human monocytes-role of quercetin metabolism. Int. J. Mol. Sci., 10, 4168-4177.
57. Shiner, M., Fuhrman, B., and Aviram, M. (2007) Macrophage paraoxonase 2 (PON2) expression is up-regulated by pomegranate juice phenolic anti-oxidants via PPAR gamma and AP-1 pathway activation. Atherosclerosis, 195, 313-321.
58. Gouédard, C., Barouki, R., and Morel, Y. (2004) Dietary polyphenols increase paraoxonase 1 gene expression by an aryl hydrocarbon receptor-dependent mechanism. Mol. Cell. Biol., 24, 5209-5222.
59. Khateeb, J., Gantman, A., Kreitenberg, A. J., Aviram, M., and Fuhrman, B. (2010) Paraoxonase 1 (PON1) expression in hepatocytes is upregulated by pomegranate polyphenols: a role for PPAR-gamma pathway. Atherosclerosis, 208, 119-125.
60. Fuhrman, B., Volkova, N., and Aviram, M. (2005) Pomegranate juice inhibits oxidized LDL uptake and cholesterol biosynthesis in macrophages. J. Nutr. Biochem., 16, 570-576.
61. Field, F. J., Born, E., and Mathur, S. N. (1997) Effect of micellar beta-sitosterol on cholesterol metabolism in CaCo-2 cells. J. Lipid. Res., 38, 348-360.
62. Rozenberg, O., Shih, D. M., and Aviram, M. (2005) Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis, 181, 9-18.
63. Rosenblat, M., Gaidukov, L., Khersonsky, O., Vaya, J., Oren, R, et al. (2006) The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux. J. Biol. Chem., 281, 7657-7665.